TMCI
Treace Medical ConceptsCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
The constructive setup is that Treace has already cut cash usage materially, guided to another roughly 50% reduction in 2026 cash usage, posted a preliminary Q1 cash increase, and now has identifiable launch hooks in SuperBite and SpeedXM that could improve surgeon wallet share if execution is clean. [#8-K-2026-04-09] [#PR-2026-04-07]
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.9.
What can break
Commercial execution risk increased after the April 8, 2026 chief commercial officer departure disclosed in the 8-K.
Momentum
96
Value
37
Sentiment
28
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.20 · Bull $3.80 · Bear $1.30
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $4.67
Why
Momentum96 · Δ7d -1.9
Value37 · Δ7d 0.0
Sentiment28 · Δ7d +1.6
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
96
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.9
Δ21d
-2.4
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.2
Sentiment
28
34% active weight
Current posture
7d trendImproving
Δ7d
+1.6
Δ21d
-1.9
Why this grade
Composite grade C. Momentum 96.4 / Value 36.5 / Sentiment 27.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$274.41M
Beta
0.74
Shares Out
64.87M
P/E (TTM) · Derived
-4.5
P/S (TTM)
0.77
P/FCF (TTM) · Derived
-10.31
Rev YoY
-10.2%
EPS YoY
+9.4%
Gross Margin
+79.7%
Op Margin
-22.1%
Net Debt
$23.5M
Current Ratio
3.58
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology